The Cell-Factory BVBA - Company Review
The Cell-Factory BVBA - Company ReviewSummary
The Cell-Factory BVBA (The Cell-Factory) a subsidiary of Esperite NV, is a biotechnology company which develops new therapies in the field of regenerative medicine. It focuses on development, clinical translation, commercialization of the allogenic extracellular vesicles biologic drugs and autologous stem cell therapies. The company’s regenerative medicine products include extracellular vesicles (EVs), exosomes and autologous stem cells for the treatment of crohn’s disease, drug-resistant epilepsy and cerebral palsy. The Cell-Factory also provides tissue engineering and cell reprogramming products. It offers its products in the therapeutic areas of neurology, orthopedics, gastroenterology, ulcers, wound healing and cardiovascular diseases. The Cell-Factory is headquartered in Niel, Belgium.
This comprehensive company report of The Cell-Factory BVBA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.